Reversal of DKK3 gene promoter methylation by demethylating reagents such as decitabine and zebularine or using a CRISPR-based approach results in increased Dkk-3 protein levels and can reduce tumor cell proliferation and migration [5,6,7,8]. Here, DKK3 is linked to neoplasm.